Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

PUBLICATION DATE

3 results
Display

Efficacy of 14 Day OBMT Therapy as a Second-line Treatment for Helicobacter pylori Infection

Park SC, Chun HJ, Jung SW, Keum B, Han WS, Choung RS, Kim YS, Jeen YT, Lee HS, Um SH, Lee SW, Choi JH, Kim CD, Ryu HS, Hyun JH

  • KMID: 1113356
  • Korean J Gastroenterol.
  • 2004 Sep;44(3):136-141.
BACKGROUND/AIMS: As a second-line treatment for H. pylori eradication in the case of first-line OAC (omeprazole, amoxicillin, clarithromycin) treatment failure, a minimum of one-week OBMT quadruple therapy composed of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Efficacy of 7-Day and 14-Day Bismuth-Containing Quadruple Therapy and 7-Day and 14-Day Moxifloxacin-Based Triple Therapy as Second-Line Eradication for Helicobacter pylori Infection

Lee ST, Lee DH, Lim JH, Kim N, Park YS, Shin CM, Jo HJ, Song IS

BACKGROUND/AIMS: Bismuth-containing quadruple and moxifloxacin-based triple regimens are recommended as second-line therapy for Helicobacter pylori infection. The aim of this study was to compare the efficacy of each regimen. METHODS: From...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Trend of Eradication Rates of Second-Line Quadruple Therapy Containing Metronidazole for Helicobacter pylori Infection: An Analysis of Recent Eight Years

Lee JH, Cheon JH, Park MJ, Kim N, Lee DH, Kim JM, Kim JS, Jung HC, Song IS

  • KMID: 1113429
  • Korean J Gastroenterol.
  • 2005 Aug;46(2):94-98.
BACKGROUND/AIMS: Failure rates of Helicobacter pylori eradication treatment turned out to be exceeding 10%, causing recurrence of peptic ulcers. In the case of eradication failure, the Korean College of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr